Entera Bio Ltd. (ENTX)
2.96
-0.05
(-1.66%)
USD |
NASDAQ |
Sep 09, 15:07
Entera Bio Price to Book Value : 20.08 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 20.42 |
| September 04, 2026 | 20.35 |
| September 03, 2026 | 20.01 |
| September 02, 2026 | 19.81 |
| September 01, 2026 | 19.67 |
| August 31, 2026 | 20.01 |
| August 28, 2026 | 20.55 |
| August 27, 2026 | 20.89 |
| August 26, 2026 | 21.64 |
| August 25, 2026 | 23.54 |
| August 24, 2026 | 23.20 |
| August 21, 2026 | 21.91 |
| August 20, 2026 | 21.84 |
| August 19, 2026 | 21.10 |
| August 18, 2026 | 19.61 |
| August 17, 2026 | 19.67 |
| August 14, 2026 | 19.61 |
| August 13, 2026 | 19.47 |
| August 12, 2026 | 18.99 |
| August 11, 2026 | 20.35 |
| August 10, 2026 | 20.62 |
| August 07, 2026 | 19.47 |
| August 06, 2026 | 19.13 |
| August 05, 2026 | 19.06 |
| August 04, 2026 | 19.47 |
| Date | Value |
|---|---|
| August 03, 2026 | 20.08 |
| July 31, 2026 | 20.28 |
| July 30, 2026 | 20.01 |
| July 29, 2026 | 20.35 |
| July 28, 2026 | 22.12 |
| July 27, 2026 | 26.59 |
| July 24, 2026 | 13.91 |
| July 23, 2026 | 14.45 |
| July 22, 2026 | 13.77 |
| July 21, 2026 | 13.30 |
| July 20, 2026 | 13.50 |
| July 17, 2026 | 13.43 |
| July 16, 2026 | 13.57 |
| July 15, 2026 | 12.08 |
| July 14, 2026 | 10.99 |
| July 13, 2026 | 11.13 |
| July 10, 2026 | 11.23 |
| July 09, 2026 | 11.53 |
| July 08, 2026 | 11.46 |
| July 07, 2026 | 11.26 |
| July 06, 2026 | 11.60 |
| July 02, 2026 | 11.26 |
| July 01, 2026 | 11.46 |
| June 30, 2026 | 12.01 |
| June 29, 2026 | 7.198 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.8026 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.755 |
| Can-Fite BioPharma Ltd. | 1.612 |
| Galmed Pharmaceuticals Ltd. | 0.3357 |
Price to Book Value Related Metrics
| PEG Ratio | -0.2280 |
| Price | 2.96 |
| Earnings Yield | -11.88% |
| Market Cap | 145.90M |
| PEGY Ratio | -0.2280 |